Ingevity completes $652.5M acquisition of Perstorp's Capa caprolactone business

Ingevity Corp. completed its purchase of the Capa caprolactone division of Perstorp Holding AB for $652.5 million, adding a plant in Warrington, England, and a new polymers line.

“The Capa division is a strong, market-leading business focused on high-growth end-use applications and is an excellent fit with Ingevity’s business model and capabilities.”chsbusinessreport.com

• 2 sources
• chsbusinessreport.comIngevity closes $652.5 million purchase of Perstorp’s Capa caprolactone business | Charleston Business ReportFeb 13, 2019
• warrington-worldwide.co.ukSpecialist chemicals business in €590m takeover dealGary SkentelberyFeb 20, 2019

Summarized from public sources; check the original articles before acting on it.